NIAID Marks Start Of Convalescent Plasma Study. The Wall Street Journal (10/8, Walker, Hopkins, Subscription Publication, 7.57M) reports that the National Institute of Allergy and Infectious Diseases announced a study testing the use of convalescent plasma in comparison to remdesivir for the treatment of coronavirus. The N

la Nunez-Smith to be COVID-19 Equity Task Force chair, Dr Anthony Fauci to be President's Chief Medical Adviser on COVID-19 (while remaining as NIH National Institute of Allergy and Infectious Diseases director), Jeff Zients to be COVID-19 response coordinator, and Natalie Quillian to be deputy COVID-19 response coordinator

ith newsworthy pronouncements from members of his White House Coronavirus Task Force, particularly coronavirus response coordinator Deborah Bin and National Institute of Allergy and Infectious Diseases Director Anthony S. Fatici". 1 The daily coronavirus task force briefings ended in late April, after a briefing at which Tr

ith newsworthy pronouncements from members of his White House Coronavirus Task Force, particularly coronavirus response coordinator Deborah Bin and National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci".E4941 The daily coronavirus task force briefings ended in late April, after a briefing at which T